{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:16:11Z","timestamp":1794366971173,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160119"],"award-info":[{"award-number":["82160119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Regional Fund Cultivation Program of The National Natural Science Foundation of China (NSFC), Affiliated Hospital of Guizhou Medical University","award":["gyfynsfc-2021-30"],"award-info":[{"award-number":["gyfynsfc-2021-30"]}]},{"name":"the Science and Technology Project of Guizhou Health and Family Planning Commission","award":["gzwkj2021-069"],"award-info":[{"award-number":["gzwkj2021-069"]}]},{"name":"the Special Research Fund of Youan Medical Alliance for the Liver and Infectious Diseases","award":["LM202001"],"award-info":[{"award-number":["LM202001"]}]},{"name":"the Starting fund for doctoral research of Affiliated Hospital of Guizhou Medical University in 2021","award":["gyfybsky-2021-68"],"award-info":[{"award-number":["gyfybsky-2021-68"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nonalcoholic steatohepatitis (NASH) is one of the most common liver diseases and has no safe and effective drug for treatment. We have previously reported the function of blueberry, but the effective monomer and related molecular mechanism remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The monomer of blueberry was examined by ultra performance liquid chromatography-mass spectrometry (UPLC-MS). The NASH cell model was constructed by exposing HepG2 cells to free fatty acids. The NASH mouse model was induced by a high-fat diet for 12\u00a0weeks. NASH cell and mouse models were treated with different concentrations of blueberry monomers. The molecular mechanism was studied by Oil Red O staining, ELISA, enzyme activity, haematoxylin\u2013eosin (H&amp;E) staining, immunohistochemistry, immunofluorescence, western blot, RNA sequencing, and qRT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified one of the main monomer of blueberry as tectorigenin (TEC). Cyanidin-3-O glucoside (C3G) and TEC could significantly inhibit the formation of lipid droplets in steatosis hepatocytes, and the effect of TEC on the formation of lipid droplets was significantly higher than that of C3G. TEC can promote cell proliferation and inhibit the release of inflammatory mediators in NASH cell model. Additionally, TEC administration provided a protective role against high-fat diets induced lipid damage, and suppressed lipid accumulation. In NASH mouse model, TEC can activate autophagy, inhibit pyroptosis and the release of inflammatory mediators. In NASH cell model, TEC inhibited pyroptosis by stimulating autophagy. Then, small RNA sequencing revealed that TEC up-regulated the expression of tRF-47-58ZZJQJYSWRYVMMV5BO (tRF-47). The knockdown of tRF-47 blunted the beneficial effects of TEC on NASH in vitro, including inhibition of autophagy, activation of pyroptosis and release of inflammatory factors. Similarly, suppression of tRF-47 promoted the lipid injury and lipid deposition in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results demonstrated that tRF-47-mediated autophagy and pyroptosis plays a vital role in the function of TEC to treat NASH, suggesting that TEC may be a promising drug for the treatment of NASH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-022-03343-5","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:03:01Z","timestamp":1647241381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The monomer TEC of blueberry improves NASH by augmenting tRF-47-mediated autophagy\/pyroptosis signaling pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Juanjuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"issue":"1","key":"3343_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3343_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, et al. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"3343_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.4161\/auto.32200","volume":"10","author":"Y Lu","year":"2014","unstructured":"Lu Y, et al. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A. Autophagy. 2014;10(11):1895\u2013905 (published correction appears in Autophagy. 2018;14 (1):176-177).","journal-title":"Autophagy"},{"issue":"5","key":"3343_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","volume":"70","author":"M Allaire","year":"2019","unstructured":"Allaire M, et al. Autophagy in liver diseases: Time for translation? J Hepatol. 2019;70(5):985\u201398.","journal-title":"J Hepatol"},{"issue":"4","key":"3343_CR5","doi-asserted-by":"publisher","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","volume":"5","author":"A Gonz\u00e1lez-Rodr\u00edguez","year":"2014","unstructured":"Gonz\u00e1lez-Rodr\u00edguez A, et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis. 2014;5(4):e1179.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3343_CR6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/hep.28820","volume":"64","author":"S Tanaka","year":"2016","unstructured":"Tanaka S, et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology. 2016;64(6):1994\u20132014.","journal-title":"Hepatology"},{"issue":"3","key":"3343_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2019.10.028","volume":"72","author":"A Hammoutene","year":"2020","unstructured":"Hammoutene A, et al. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. J Hepatol. 2020;72(3):528\u201338.","journal-title":"J Hepatol"},{"issue":"9","key":"3343_CR8","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","volume":"17","author":"HS Park","year":"2021","unstructured":"Park HS, et al. TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Autophagy. 2021;17(9):2549\u201364.","journal-title":"Autophagy"},{"issue":"7329","key":"3343_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135 (published correction appears in Nature. 2011 Jul 7;475(7354):122).","journal-title":"Nature"},{"issue":"2","key":"3343_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389-97.e10.","journal-title":"Gastroenterology"},{"issue":"1","key":"3343_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74(1):156\u201367.","journal-title":"J Hepatol"},{"issue":"10","key":"3343_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41419-018-1004-0","volume":"9","author":"T Qiu","year":"2018","unstructured":"Qiu T, et al. Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway. Cell Death Dis. 2018;9(10):946.","journal-title":"Cell Death Dis"},{"key":"3343_CR13","doi-asserted-by":"publisher","first-page":"172715","DOI":"10.1016\/j.ejphar.2019.172715","volume":"864","author":"X Yu","year":"2019","unstructured":"Yu X, et al. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur J Pharmacol. 2019;864:172715.","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"3343_CR14","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1101\/gad.1837609","volume":"23","author":"YS Lee","year":"2009","unstructured":"Lee YS, et al. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 2009;23(22):2639\u201349.","journal-title":"Genes Dev"},{"issue":"1","key":"3343_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-020-00955-6","volume":"13","author":"M Yu","year":"2020","unstructured":"Yu M, et al. tRNA-derived RNA fragments in cancer: current status and future perspectives. J Hematol Oncol. 2020;13(1):121.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"3343_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41422-019-0175-2","volume":"29","author":"F Zhong","year":"2019","unstructured":"Zhong F, et al. Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis. Cell Res. 2019;29(7):548\u201361.","journal-title":"Cell Res"},{"key":"3343_CR17","doi-asserted-by":"publisher","first-page":"118125","DOI":"10.1016\/j.lfs.2020.118125","volume":"257","author":"J Zhu","year":"2020","unstructured":"Zhu J, Cheng M, Zhao X. A tRNA-derived fragment (tRF-3001b) aggravates the development of nonalcoholic fatty liver disease by inhibiting autophagy. Life Sci. 2020;257:118125.","journal-title":"Life Sci"},{"issue":"12","key":"3343_CR18","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1039\/C8FO01227J","volume":"9","author":"J Zhu","year":"2018","unstructured":"Zhu J, et al. Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1\/STAT3\/BAX signaling. Food Funct. 2018;9(12):6298\u2013306.","journal-title":"Food Funct"},{"key":"3343_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2147\/DDDT.S111625","volume":"10","author":"J Zhu","year":"2016","unstructured":"Zhu J, et al. The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway. Drug Des Devel Ther. 2016;10:1649\u201361.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"3343_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/nu9030198","volume":"9","author":"T Ren","year":"2017","unstructured":"Ren T, et al. The combination of blueberry juice and probiotics ameliorate non-alcoholic steatohepatitis (NASH) by affecting SREBP-1c\/PNPLA-3 pathway via PPAR-\u03b1. Nutrients. 2017;9(3):198.","journal-title":"Nutrients"},{"issue":"1","key":"3343_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jnutbio.2003.07.004","volume":"15","author":"F Galvano","year":"2004","unstructured":"Galvano F, et al. Cyanidins: metabolism and biological properties. J Nutr Biochem. 2004;15(1):2\u201311.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"3343_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jnutbio.2010.12.013","volume":"23","author":"H Guo","year":"2012","unstructured":"Guo H, Xia M, Zou T, et al. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db\/db mice via the transcription factor FoxO1. J Nutr Biochem. 2012;23(4):349\u201360.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"3343_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/ptr.6299","volume":"33","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4\/mitogen-activated protein kinase and TLR4\/nuclear factor-\u03baB pathways and autophagy. Phytother Res. 2019;33(4):1055\u201364.","journal-title":"Phytother Res"},{"key":"3343_CR24","doi-asserted-by":"publisher","first-page":"106195","DOI":"10.1016\/j.intimp.2020.106195","volume":"81","author":"H Shi","year":"2020","unstructured":"Shi H, et al. Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis. Int Immunopharmacol. 2020;81:106195.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"3343_CR25","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3109\/13880209.2014.993038","volume":"53","author":"QY Li","year":"2015","unstructured":"Li QY, et al. Tectorigenin regulates adipogenic differentiation and adipocytokines secretion via PPAR\u03b3 and IKK\/NF-\u03baB signaling. Pharm Biol. 2015;53(11):1567\u201375.","journal-title":"Pharm Biol"},{"issue":"4","key":"3343_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CAD.0000000000001032","volume":"32","author":"F Zhao","year":"2021","unstructured":"Zhao F, et al. 3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy. Anticancer Drugs. 2021;32(4):386\u201393.","journal-title":"Anticancer Drugs"},{"issue":"8","key":"3343_CR27","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s12272-012-0819-y","volume":"35","author":"XX Gao","year":"2012","unstructured":"Gao XX, et al. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Arch Pharm Res. 2012;35(8):1479\u201393.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"3343_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcmgh.2019.10.010","volume":"9","author":"A Tutusaus","year":"2020","unstructured":"Tutusaus A, et al. A functional role of GAS6\/TAM in nonalcoholic steatohepatitis progression implicates AXL as therapeutic target. Cell Mol Gastroenterol Hepatol. 2020;9(3):349\u201368.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"3343_CR29","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.4049\/jimmunol.0903664","volume":"185","author":"H Tang","year":"2010","unstructured":"Tang H, et al. TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice. J Immunol. 2010;185(4):2563\u20139.","journal-title":"J Immunol"},{"key":"3343_CR30","first-page":"8351342","volume":"2020","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. MicroRNA-103 protects coronary artery endothelial cells against H2O2-induced oxidative stress via BNIP3-mediated end-stage autophagy and antipyroptosis pathways. Oxid Med Cell Longev. 2020;2020:8351342.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"3343_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora EE, et al. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15(5):261\u201373.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"3343_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso G, Cassader M, Gambino R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov. 2016;15(4):249\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"3343_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.trac.2019.05.009","volume":"116","author":"E Ahmadian","year":"2019","unstructured":"Ahmadian E, et al. The potential of nanomaterials in theranostics of oral squamous cell carcinoma: recent progress. Trends Analyt Chem. 2019;116:167\u201376.","journal-title":"Trends Analyt Chem"},{"issue":"24","key":"3343_CR34","doi-asserted-by":"publisher","first-page":"13424","DOI":"10.3390\/ijms222413424","volume":"22","author":"G Tarantino","year":"2021","unstructured":"Tarantino G, et al. It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them? Int J Mol Sci. 2021;22(24):13424.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3343_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2011.10.483","volume":"52","author":"W Zhu","year":"2012","unstructured":"Zhu W, et al. The anthocyanin cyanidin-3-O-\u03b2-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP-PKA-dependent signaling pathway. Free Radic Biol Med. 2012;52(2):314\u201327.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3343_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng Y, et al. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int. 2021;15(1):21\u201335.","journal-title":"Hepatol Int"},{"key":"3343_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11094-018-1724-6","volume":"51","author":"A Eftekhari","year":"2018","unstructured":"Eftekhari A, et al. The effects of cimetidine, N-acetylcysteine, and taurine on thioridazine metabolic activation and induction of oxidative stress in isolated rat hepatocytes. Pharm Chem J. 2018;51:965\u20139.","journal-title":"Pharm Chem J"},{"issue":"7242","key":"3343_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135.","journal-title":"Nature"},{"issue":"2","key":"3343_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/j.gastro.2015.09.042","volume":"150","author":"J Madrigal-Matute","year":"2016","unstructured":"Madrigal-Matute J, Cuervo AM. Regulation of liver metabolism by autophagy. Gastroenterology. 2016;150(2):328\u201339.","journal-title":"Gastroenterology"},{"issue":"3","key":"3343_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","volume":"40","author":"D Senft","year":"2015","unstructured":"Senft D, Ronai ZA. UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. 2015;40(3):141\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"3343_CR41","doi-asserted-by":"publisher","first-page":"e66417","DOI":"10.1371\/journal.pone.0066417","volume":"8","author":"Q Wang","year":"2013","unstructured":"Wang Q, et al. Tectorigenin attenuates palmitate-induced endothelial insulin resistance via targeting ROS-associated inflammation and IRS-1 pathway. PLoS ONE. 2013;8(6):e66417.","journal-title":"PLoS ONE"},{"issue":"9","key":"3343_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/biom9090435","volume":"9","author":"B Liu","year":"2019","unstructured":"Liu B, et al. Raw bowl tea (Tuocha) polyphenol prevention of nonalcoholic fatty liver disease by regulating intestinal function in mice. Biomolecules. 2019;9(9):435.","journal-title":"Biomolecules"},{"issue":"1","key":"3343_CR43","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","volume":"7","author":"D Zhou","year":"2017","unstructured":"Zhou D, et al. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci Rep. 2017;7(1):1529.","journal-title":"Sci Rep"},{"key":"3343_CR44","doi-asserted-by":"publisher","first-page":"568894","DOI":"10.3389\/fcell.2020.568894","volume":"8","author":"SAA Moqbel","year":"2020","unstructured":"Moqbel SAA, et al. Tectorigenin alleviates inflammation, apoptosis, and ossification in rat tendon-derived stem cells via modulating NF-Kappa B and MAPK pathways. Front Cell Dev Biol. 2020;8:568894.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"3343_CR45","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1038\/s41598-021-85421-0","volume":"11","author":"P Huang","year":"2021","unstructured":"Huang P, et al. Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease. Sci Rep. 2021;11(1):5886.","journal-title":"Sci Rep"},{"key":"3343_CR46","doi-asserted-by":"publisher","first-page":"105986","DOI":"10.1016\/j.aquatox.2021.105986","volume":"240","author":"M Guo","year":"2021","unstructured":"Guo M, et al. Zinc antagonizes common carp (Cyprinus carpio) intestinal arsenic poisoning through PI3K\/AKT\/mTOR signaling cascade and MAPK pathway. Aquat Toxicol. 2021;240:105986.","journal-title":"Aquat Toxicol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03343-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03343-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03343-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T15:04:27Z","timestamp":1650294267000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03343-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3343"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03343-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal care and ethical committee of Affiliated Hospital of Guizhou Medical University approved our protocols. All animal-handling procedures were performed according to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and followed the guidelines of the Animal Welfare Act.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}